| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283861A2 Method for Treating Thrombocytopenia with Monoclonal IVIG |
| 02/16/2011 | EP2283856A1 Stabilised solid compositions of factor VII polypeptides |
| 02/16/2011 | EP2283851A2 Compositions and methods for promoting hemostasis and other physiological activities |
| 02/16/2011 | EP2283839A1 Polyunsaturated hydroxylated molecule having an eze geometry and its use in therapy |
| 02/16/2011 | EP2283809A1 Microneedle array using porous substrate and process for producing same |
| 02/16/2011 | EP2283022A1 Furo ý3, 2-b¨pyrr0l-3-0nes as cathepsin s inhibitors |
| 02/16/2011 | EP2283011A1 2-phenyl-4-cyclopropyl-pyrimidine derivatives |
| 02/16/2011 | EP2282775A2 Vector for use in medicine |
| 02/16/2011 | EP1222854B1 Prevention and treatment of diseases associated with blood coagulation |
| 02/16/2011 | CN1814193B Chinese medicine composition for treating nephritis dropsy and preparation method thereof |
| 02/16/2011 | CN101978046A Uses and isolation of very small embryonic-like (vsel) stem cells |
| 02/16/2011 | CN101977945A Anti-microbial polymers and their compositions |
| 02/16/2011 | CN101977654A Von willebrand factor specific binders and methods of use therefor |
| 02/16/2011 | CN101977603A Methods using immunomodulatory compounds for modulating level of cd59 |
| 02/16/2011 | CN101974395A Powerful antifatigue super oxide dismutase (SOD) health wine and preparation method thereof |
| 02/16/2011 | CN101974391A Wine with functions of resisting thrombosis, lowering blood lipid and expelling toxins and production method thereof |
| 02/16/2011 | CN101974068A Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
| 02/16/2011 | CN101974015A Ester compound and preparation method and application thereof |
| 02/16/2011 | CN101974011A New compound methyl brevicate with medical activity |
| 02/16/2011 | CN101973925A 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof |
| 02/16/2011 | CN101972457A Chinese medicinal composition for treating edema during menstruation and preparation method thereof |
| 02/16/2011 | CN101972424A Traditional Chinese medicine for treating cirrhosis ascites |
| 02/16/2011 | CN101972421A Drug for treating hemoptysis and preparation method thereof |
| 02/16/2011 | CN101972411A Medicament for treating cerebral apoplexy |
| 02/16/2011 | CN101972403A Medicinal liquor for treating white hair |
| 02/16/2011 | CN101972375A Soup for treating hemiplegia and strengthening body resistance |
| 02/16/2011 | CN101972351A Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura |
| 02/16/2011 | CN101972348A Method for extracting total saponin from leaves of rehmannia |
| 02/16/2011 | CN101972333A Medicament for eliminating turbid urines and activating blood stasis |
| 02/16/2011 | CN101972320A Method for extracting ferulic acid, chlorogenic acid and other aicd components from coptis chinensis franch |
| 02/16/2011 | CN101972279A External traditional Chinese medicine for treating cerebral thrombosis |
| 02/16/2011 | CN101972268A Compound medicine for treating thrombus |
| 02/16/2011 | CN101972240A Modafinil Composition |
| 02/16/2011 | CN101647894B Haemostasia medicine of Chinese herbs |
| 02/16/2011 | CN101619054B New coumarin active content, preparation method and application thereof |
| 02/16/2011 | CN101508739B Radio frequency auxiliary method for extracting glossy ganoderma seed polysaccharide |
| 02/16/2011 | CN101254209B Calf spleen extract injection prepared by inphase opposition column chromatography and preparation thereof |
| 02/16/2011 | CN101156894B Detection method of apricot red injection |
| 02/15/2011 | US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 02/15/2011 | US7888369 Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
| 02/15/2011 | CA2624949C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 02/15/2011 | CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2334863C Antithrombotic compounds |
| 02/15/2011 | CA2263647C Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | WO2011015599A1 Prasugrel in non-crystalline form and pharmaceutical composition thereof |
| 02/10/2011 | US20110034539 Methods for treating blood coagulation disorders |
| 02/10/2011 | US20110034467 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof |
| 02/10/2011 | US20110034465 Processes for the preparation of rivaroxaban and intermediates thereof |
| 02/10/2011 | US20110034461 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034458 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 02/10/2011 | US20110034456 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034453 Aminoacyl Prodrug Derivatives and Medicaments for the Treatment of Thromboembolitic Disorders |
| 02/10/2011 | US20110034452 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034451 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034450 Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof |
| 02/10/2011 | US20110034389 Active agents, compositions, and methods for inhibiting and reversing platelet function |
| 02/10/2011 | US20110034378 Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc. |
| 02/10/2011 | US20110033554 Method of Viral Inactivation of Biological Fluids |
| 02/10/2011 | US20110033553 Embolization |
| 02/10/2011 | US20110033535 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 02/10/2011 | US20110033505 Methods and compositions for treatment of ion imbalances |
| 02/10/2011 | US20110033474 Inhibition of platelet aggregation |
| 02/10/2011 | US20110033459 Combination therapy with a compound acting as a platelet adp receptor inhibitor |
| 02/10/2011 | US20110033454 Methods For Treating Diseases Using Antibodies to Aminophospolipids |
| 02/10/2011 | US20110033418 Treatment of diseases caused by viral infection |
| 02/10/2011 | US20110033414 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 02/10/2011 | DE102009036646A1 Prasugrel in nicht-kristalliner Form und pharmazeutische Zusammensetzung davon Prasugrel in non-crystalline form and pharmaceutical composition thereof |
| 02/09/2011 | EP2281828A2 Compositions comprising modified erythropoietin |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP2280983A2 C-aryl glycoside compounds for the treatment of diabetes and obesity |
| 02/09/2011 | EP2280976A1 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines as gsk3beta-inhibitors |
| 02/09/2011 | EP2280964A1 Chlorothiophene-isoxazoles as inhibitors of coagulation factors xa and thrombin |
| 02/09/2011 | EP2280928A2 Vinyl substituted fatty acids |
| 02/09/2011 | EP2280734A2 Factor ix conjugates with extended half-lives |
| 02/09/2011 | EP2280695A1 Hydroxytyrosol benefits mitochondria |
| 02/09/2011 | EP2044946B1 Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them |
| 02/09/2011 | EP1459738B1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 02/09/2011 | EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 02/09/2011 | EP1370276B1 Intercellular communication facilitating compounds and their medical use |
| 02/09/2011 | EP0771324B2 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 02/09/2011 | CN1951449B Medicament for increasing peripheral blood leukocyte and use thereof |
| 02/09/2011 | CN1889937B Glycopegylated factor IX |
| 02/09/2011 | CN1827638B Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 02/09/2011 | CN101969984A Haemostasis- modulating compositions and uses therefor |
| 02/09/2011 | CN101969955A Methods of treating thromboembolic disorders |
| 02/09/2011 | CN101969953A Pterin analog for treating bh4 responsive condition |
| 02/09/2011 | CN101969941A Amino acid derivatives used as pharmaceutical substances |
| 02/09/2011 | CN101967205A Beta-dextriferron composite and preparation method thereof |
| 02/09/2011 | CN101967195A Thrombolysis-targeting fusion protein mAnxB1ScuPA, structure and application thereof |
| 02/09/2011 | CN101967183A Artificially synthesized novel antithrombotic peptide derivative, preparation method and application thereof |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101966300A Chinese medicinal composition for treating leucorrhoea hemorrhage and preparation method thereof |